First volunteers receive vaccine for Crimean-Congo haemorrhagic fever in Oxford clinical trial

Published on September 12, 2023

A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time. Launched on the 4th of August 2023, the clinical trial of the ChAdOx2 CCHF vaccine aims to confirm its safety and understand how individuals develop immunity following vaccination. 
Continue reading on website
Other news

E-cigarettes, Varenicline and Cytisine found to be the most effective stop-smoking aids

September 12, 2023
A comprehensive new analysis has found that nicotine e-cigarettes, varenicline and cytisine are the most effective options currently available for helping smokers quit long-term (going at least six months without smoking).

Older 'Family Fortunes Voters' influenced by financial struggles of younger relatives

September 12, 2023
Older generations, concerned about younger family members who are struggling financially, could be motivated in the next General Election to support policies to help out the young, according to research today [13 Sept].